ArticleJournal of minimally invasive surgery2025
Approaches in treating infiltrative common bile duct cancer: the potential of robotic hepatopancreatoduodenectomy.
Article in Journal of minimally invasive surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Transitioning to the robotic era for perihilar cholangiocarcinoma: initial implementation and outcomes in a single center.Surgical endoscopy · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatopancreatoduodenectomy (HPD) is a definitive, yet highly complex surgical approach for treating extensive cholangiocarcinoma, characterized by substantial morbidity and mortality. Recent advancements in minimally invasive surgery, particularly robotic platforms, have demonstrated potential in overcoming the technical challenges associated with HPD. Here, we present a case of a 69-year-old male with hilar cholangiocarcinoma extending to the mid and distal common bile duct, successfully managed with robotic left hepatectomy, caudate lobectomy, and pancreaticoduodenectomy (HPD). The operation, performed using the da Vinci Xi system (Intuitive Surgical), lasted 543 minutes with an estimated blood loss of 500 mL. Postoperative complications, including a hepaticojejunostomy leakage, were managed conservatively, and the patient was discharged. This case highlights the feasibility and safety of robotic HPD for complex biliary malignancies, emphasizing its potential as a minimally invasive alternative in select patients when performed by experienced surgeons.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.